Net Element Announces Filing of Preliminary Proxy Statement

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Net Element Announces Filing of Preliminary Proxy Statement for Reverse Stock Split

MIAMI, FL--(Marketwired - Oct 8, 2015) - Net Element, Inc. ( NASDAQ : NETE ) ("Net Element" or the "Company"), a provider of global mobile payment technology solutions and value-added transactional services, announced today that it will hold a special meeting of stockholders to approve amendments to the Company's certificate of incorporation, which would effect a reverse stock split of the Company's common stock at a ratio of between 1 for 20 and 1 for 30, inclusive, which ratio will be selected at the sole discretion of the Company's board of directors and to approve the issuance by the Company of restricted shares of common stock issuable pursuant to the terms of the Insider Financing agreement dated September 11, 2015.

The reverse stock split and the Insider Financing agreement are subject to the approval of Net Element's shareholders. The Company filed a preliminary proxy statement with the SEC today for a special meeting of shareholders at which time the above referenced approvals will be sought. The date and other details of the special meeting will be communicated to shareholders at a later date. The Company currently expects to complete the reverse split by the end of the fourth quarter of 2015.

"Our intent is to continue to trade on the NASDAQ Capital Market," said Oleg Firer, CEO of Net Element. "To that end and after careful evaluation of our options, we have decided to pursue a reverse stock split to regain compliance with the minimum bid price requirement of the NASDAQ Capital Market. In addition to our goal of sustaining our NASDAQ listing, we believe a higher share price resulting from a reverse stock split could help broaden our shareholder base by increasing the number of potential long-term investors."

Stockholders and investors are urged to read the Company's Preliminary Proxy Statement that is being filed today in preliminary form with the SEC in connection with the proposed amendments to the certificate of incorporation and the reverse stock split. These materials contain important information regarding the reverse stock split and may be obtained from the SEC's Internet website at http://www.sec.gov . A copy of the Preliminary Proxy Statement may also be obtained from Net Element through its investor relations section of the website.

About Net Element

Net Element, Inc. ( NASDAQ : NETE ) operates a payments-as-a-service platform for small to medium enterprise ("SME") in the US, Russian Federation and other international markets. In the US it aims to grow transactional revenue by innovating SME productivity services such as its cloud based, restaurant point-of-sale solution Aptito. Internationally, Net Element's strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions such as UAE, Kazakhstan, India and Latin America. It maintains offices in Miami, FL and in Russia. Further information is available at www.netelement.com .

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Any statements contained in this press release that are not statements of historical fact may be deemed forward-looking statements. Words such as "continue," "will," "may," "could," "should," "expect," "expected," "plans," "intend," "anticipate," "believe," "estimate," "predict," "potential," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include, without limitation, whether Net Element can regain compliance with the minimum closing bid price requirements of NASDAQ for the Company's common stock, and there can be no assurance that the Company will continue to meet the other listing requirements of The NASDAQ Capital Markets. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, many of which are generally outside the control of Net Element and are difficult to predict. Examples of such risks and uncertainties include, but are not limited to: (i) ) if the reverse stock split is approved and implemented and the market price of the Company's common stock declines, the percentage decline may be greater than would occur in the absence of the reverse stock split; (ii) there can be no assurance that the reverse stock split will increase the per share price for the Company's common stock or result in a permanent increase in the per share price, which depends on many factors, including our performance, prospects and other factors that may be unrelated to the number of shares outstanding; (iii) the Company will have fewer shares that are publicly traded which may result in a decline of the trading liquidity of the Company's common stock may decline; (iv) if in the future the market price of the Company's common stock following the reverse stock split may not exceed or remain higher than the market price prior to the reverse stock split; (v) the number of shares of the Company's common stock available for future issuance will effectively be increased after the reverse stock split, which potentially allows the Company to raise additional capital in the future through the issuance and sale of equity securities from time to time, as the Board of Directors may deem advisable, and the issuance in the future of such additional authorized shares may have the effect of diluting the earnings or loss per share and book value per share, as well as the ownership and voting rights of the holders of our then-outstanding shares of capital stock; (vi) Net Element's ability to successfully expand in existing markets and enter new markets; (vii) Net Element's ability to successfully manage and integrate any acquisitions of businesses, solutions or technologies; (viii) unanticipated operating costs, transaction costs and actual or contingent liabilities; (ix) the ability to attract and retain qualified employees and key personnel; (x) adverse effects of increased competition on Net Element's business; (xi) changes in government licensing and regulation that may adversely affect Net Element's business; (xii) the risk that changes in consumer behavior could adversely affect Net Element's business; (xiii) Net Element's ability to protect its intellectual property; (xiv) local, industry and general business and economic conditions; (xv) adverse effects of potentially deteriorating U.S.-Russia relations, including, without limitation, over a conflict related to Ukraine, including a risk of further U.S. government sanctions or other legal restrictions on U.S. businesses doing business in Russia. Additional factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements can be found in the most recent annual report on Form 10-K and the subsequently filed quarterly reports on Form 10-Q and current reports on Form 8-K filed by Net Element with the Securities and Exchange Commission. Net Element anticipates that subsequent events and developments may cause its plans, intentions and expectations to change. Net Element assumes no obligation, and it specifically disclaims any intention or obligation, to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law.

Contact: Media Net Element, Inc. media@netelement.com +1 (786) 923-0502

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Cardiovalve's Three-Year Data Clears a Crucial EU Hurdle

Updated Category News Views 16

A failing tricuspid valve is not a spreadsheet problem, and that matters before anybody gets carried away with a glossy conference presentation. Venus Medtech's Cardiovalve unit has reported results from TARGET in a population that was old, sick and largely out of good surgical options. That is precisely where a less invasive replacement therapy has to prove it can do...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 310

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 37

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 348

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 386

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 332

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 270

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 513

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading

Top 5 Most Recently Viewed Articles

Motorsport Games Achieves Significant Growth in Q3 Results

Updated Category News Views 182

Motorsport Games Shows Promising Financial Trends Motorsport Games Inc. (NASDAQ: MSGM) recently shared its financial outcomes for the third quarter, reflecting remarkable growth. The company, a key player in the racing game industry, recorded significant advancements, particularly highlighted by their flagship title, Le Mans Ultimate. For Q3 2025, Motorsport Games...

Continue Reading
AI Giants Converge in Singapore for SuperAI 2026

Updated Category News Views 52

SuperAI Singapore 2026: A Global Gathering Singapore's Marina Bay Sands is buzzing, folks. With 10,000 people crammed into Asia's largest AI event, SuperAI Singapore 2026 is offering up a melting pot of tech brains from 150 countries. It's sold out like your favorite band’s farewell tour—things kicking off with a big bang. A Melting Pot of Innovation You’ve got...

Continue Reading
Investors' Sentiment Towards Terreno Realty Corp Revealed

Updated Category News Views 128

Understanding Investor Sentiment for Terreno Realty Corp Terreno Realty's short interest has notably surged, reflecting a growing sentiment among investors. Currently, 11.02% increase in short interest reveals that now approximately 6.22 million shares are sold short, making it 10.78% of the float. Observing the trading volume suggests that it would take traders roughly...

Continue Reading
Gilead Sciences Targets Growth Amid Oncology Challenges and Opportunities

Updated Category News Views 208

Gilead Sciences faced significant challenges back in 2024 as its oncology ambitions faltered, all while the company leaned heavily on its HIV stronghold. The stock stumbled, reflecting broader market jitters about its future growth potential. You see, Gilead had been riding high on Biktarvy, a blockbuster that held nearly 49% of the U.S. HIV treatment market. Analysts...

Continue Reading
Captify Launches Innovative Election War Room Insights 2024

Updated Category News Views 124

Captify Launches the Election War Room for the 2024 Elections Captify, a leader in real-time audience analytics powered by Search Intelligence, has introduced the Captify Election War Room—a weekly data report that spotlights what people are searching for during the 2024 U.S. election cycle. As the race intensifies, brands and campaign teams want a clearer view of how...

Continue Reading